Dr. Leon Reyfman of Pain Management NYC introduces high-frequency Spinal Cord Stimulation (SCS), a non-drug, FDA-approved solution for chronic diabetic neuropathy pain, offering hope to patients who have failed traditional therapies.
NEW YORK, Feb. 2, 2026 /PRNewswire-PRWeb/ -- Dr. Leon Reyfman of Pain Management NYC announced the availability of high-frequency spinal cord stimulation (SCS), an FDA-approved, minimally invasive treatment option for patients suffering from painful diabetic peripheral neuropathy.
Peripheral nerve damage is one of the most debilitating complications associated with diabetes and can significantly impair mobility, sleep, and overall quality of life. Many patients continue to experience chronic pain despite treatment with medications, physical therapy, and lifestyle modifications.
High-frequency, 10-kHz spinal cord stimulation is designed to modulate pain signals before they reach the brain, without the paresthesia commonly associated with traditional spinal cord stimulation therapies. The treatment has been used in pain management for over a decade and is now FDA-approved for painful diabetic peripheral neuropathy.
Clinical research published in JAMA Neurology reported that a substantial percentage of patients treated with 10-kHz high-frequency SCS experienced meaningful pain reduction, with many maintaining improvement at 12 months. The study also noted preservation of lower-limb function in the majority of patients who transitioned from standard medical therapy.
"The pain reduction observed in patients treated with high-frequency spinal cord stimulation has been highly encouraging," said Dr. Leon Reyfman. "For patients whose neuropathy has significantly diminished their quality of life, this therapy offers a minimally invasive option that may help restore daily function."
With millions of Americans affected by Type 1 and Type 2 diabetes, there is a growing demand for non-drug treatment options that address chronic neuropathic pain while minimizing systemic side effects. High-frequency spinal cord stimulation may be considered for carefully selected patients when conservative treatments fail to provide adequate relief.
"At Pain Management NYC, we always begin with the least invasive approaches," Dr. Reyfman added. "When pain becomes persistent and disruptive to daily life, advanced interventional therapies such as spinal cord stimulation may offer an appropriate next step under the care of experienced specialists."
High-frequency spinal cord stimulation for painful diabetic neuropathy is now available at Pain Management NYC.
To arrange an interview or learn more, visit https://www.painmanagementnyc.com/ or contact Dr. Reyfman at (212) 224-9555.
About Leon Reyfman, MD, FIPP, FRCP
- Diplomate, American Board of Anesthesiology and Pain Medicine
- Fellow, Interventional Pain Practice
- Fellow, Royal College of Physicians & Surgeons
- Assistant Clinical Professor of Anesthesiology, SUNY Downstate Medical Center
- Mount Sinai Hospital
Media Contact
Leon Reyfman, MD
Pain Management NYC
Website: https://www.painmanagementnyc.com/
Phone: (212) 224-9555
Address: 240 E 23rd St., New York, NY 10010
SOURCE Pain Management NYC
Share this article